Physician profile
Daniel R Cook
NPI 1417123456
$2,958.42
in general payments reported to CMS, 2019-2025
12 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,452 · 2020: $391 · 2021: $406 · 2022: $118 · 2023: $188 · 2024: $195 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $1,016.04 | 2019-2022 | |
| Stryker Corporation | $403.11 | 2021-2025 | Na, Patient-Fitted Tmj Reconstructive Prosthesis System, Vsp System, Vsp Cranial |
| Salvin Dental Specialties, INC. | $341.45 | 2019-2021 | |
| Straumann USA LLC | $338.99 | 2020-2024 | |
| Zimmer Biomet Holdings, INC. | $335.71 | 2019-2023 | Advantagerib, Sternalock Blu System |
| Dentsply Sirona INC | $183.67 | 2019-2021 | |
| Kls-Martin L.P. | $134.27 | 2019-2020 | |
| Geistlich Pharma, North America, INC. | $73.69 | 2024 | Geistlich Bio-Gide |
| Heron Therapeutics, INC. | $53.71 | 2021-2022 | |
| Peerless Surgical INC. | $32.37 | 2023 | |
| Dentsply Ih INC. | $29.88 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.53 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.